It has to be pointed out, however, that the prevalence of TERT promoter mutations is not high (10%–20%) in differentiated thyroid cancer, and the exclusion of malignancy should not be only based on undetectable TERT promoter mutations. The gene discussed is TERT; the disease is thyroid gland carcinoma.